ORF08-04 - Safety and Efficacy of Garetosmab in Adults with Fibrodysplasia Ossificans Progressiva: Week 56 Results from the Phase 3 OPTIMA Study

Co-Author(s)

• RP

  Riccardo Papa, MD

  IRCCS Istituto Giannina Gaslini
  Genova, Italy
• SR

  Susan Rhee, MD

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, New York, United States
• PD

  Patricia Delai, MD

  Hospital Israelita Albert Einstein, Instituto de Ensino e Pesquisa
  São Paulo, Brazil
• KZ

  Keqin Zhang, n/a

  Tongji Hospital, Shanghai Tongji University
  Shanghai, China (People's Republic)
• IB

  Ignacio Briceño Balcázar, n/a

  Universidad de La Sabana, Fibrodisplasia osificante progresiva en Colombia
  Chia, Colombia
• EI

  Erik Iván Quevedo Langenegger, n/a

  Clínica Inmunomédica, Universidad de Concepción
  Concepción, Chile
• KR

  Kavitha Rethanavelu, n/a

  Kuala Lumpur Hospital
  Kuala Lumpur, Malaysia
• TF

  Toshifumi Fujiwara, MD

  Kyushu University Hospital
  Fukuoka, Japan
• KM

  Kenichi Mishima, MD

  Nagoya University Hospital
  Nagoya, Japan
• JT

  Jacek Tabarkiewicz, n/a

  Medical College of University of Rzeszów
  Rzeszów, Poland
• TF

  Thomas Funck-Brentano, n/a

  Lariboisière Hospital AP-HP
  Paris, France
• RS

  Raphaella Stander, n/a

  University of Cape Town
  Cape Town, South Africa
• JB

  Javier Bachiller-Corral, n/a

  Hospital Universitario Ramón y Cajal
  Madrid, Spain
• KD

  Kathryn M. Dahir, MD

  Vanderbilt University Medical Center, United States
• EE

  E. Marelise W. Eekhoff, n/a

  Amsterdam University Medical Center
  Amsterdam, Netherlands
• MH

  Matti Hero, n/a

  New Children’s Hospital, Helsinki University Hospital
  Helsinki, Finland
• EK

  Evelyn Kuong, n/a

  Queen Mary Hospital
  Hong Kong, Hong Kong
• NU

  Naoto Uemura, MD, PhD

  Oita University
  Oita, Japan
• MZ

  Meijian Zhou, n/a

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, New York, United States
• DG

  Dinko Gonzalez Trotter, n/a

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, New York, United States
• JG

  Jing Gu, Ph.D.

  REGENERON PHARM INC
  Sleepy Hollow, NY, United States
• DO

  Donal O’Donovan, n/a

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, New York, United States
• RP

  Robert Pordy, MD

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, New York, United States
• BH

  Boaz Hirshberg, n/a

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, New York, United States
• GY

  George D. Yancopoulos, n/a

  Regeneron Pharmaceuticals, Inc.
  Tarrytown, New York, United States

Oral Abstract Presenter(s)

• 

  Richard Keen, MD PhD

  Royal National Orthopaedic Hospital
  Stanmore, United Kingdom